BCM
IHI icon

BlueCrest Capital Management’s iShares US Medical Devices ETF IHI Stock Holding History

BlueCrest Capital Management’s Portfolio IHI Stock Details IHI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-7,800
Closed -$421K – 262
2023
Q1 		$421K Buy
+7,800
New +$415K 0.01% 196

Other funds holding IHI

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $9.12B AUM 42.07% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

BlueCrest Capital Management's IHI Position: Q2 2023 in Review

BlueCrest Capital Management sold out of iShares US Medical Devices ETF (IHI) in Q2 2023, closing a stake of 7,800 shares — an estimated $421K sold.

BlueCrest Capital Management first reported a position in IHI in Q1 2023 and held it in 1 quarter. The position peaked at $421K in Q1 2023. 585 funds tracked by Wall St. Rank hold IHI as of Q2 2023.

  • BlueCrest Capital Management reported no remaining iShares US Medical Devices ETF position as of Q2 2023 after selling out during the quarter.
  • BlueCrest Capital Management sold 7,800 iShares US Medical Devices ETF shares in Q2 2023, an estimated $421K.
  • BlueCrest Capital Management first reported a position in iShares US Medical Devices ETF in Q1 2023 and held it in 1 quarter.
  • BlueCrest Capital Management's iShares US Medical Devices ETF position peaked at $421K in Q1 2023.
  • 585 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2023.

Based on BlueCrest Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.